Program Directors

Hossein Borghaei, DO, MS
Chief, Division of Thoracic Medical Oncology; Professor, Department of Hematology/Oncology; Co-Director, Immune Monitoring Facility; Gloria and Edmund M. Dunn Chair in Thoracic Oncology, Fox Chase Cancer Center

Joseph Friedberg, MD, FACSThoracic Surgeon-in-Chief, Temple University Health System Vice Chair, Surgical Services, Department of Thoracic Medicine and Surgery Co-Director, Temple-Fox Chase Cancer Center Mesothelioma and Pleural Disease Program Professor, Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University

Presenters and Topics

Evaluation of a Surgical Patient

Gerard J. Criner, MD, FACP, FACCP
Director, Temple Lung Center; Founding Chair and Professor, Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University

Adjuvant Chemo/IO/Targeted Therapies

Martin J. Edelman, MD Chair and Professor, Department of Hematology/Oncology; Deputy Cancer Center Director for Clinical Research; G. Morris Dorrance Jr. Chair in Medical Oncology, Fox Chase Cancer Center

Radiation and Early Stage Lung Cancer

Sameera Kumar, MD
Assistant Professor, Department of Radiation Oncology, Fox Chase Cancer Center

Bronchoscopy and EBUS for Diagnosis and Staging

Christopher J. Manley, MD
Director, Interventional Pulmonology; Associate Professor, Department of Medicine, Fox Chase Cancer Center

Surgical Approaches

Stacey Su, MD, FACS, Fox Chase Cancer Center
Chief, Division of Thoracic Surgery; Associate Professor, Department of Surgical Oncology; Director, Thoracic Oncology Fellowship Training Program

Neoadjuvant Chemo-IO

Joseph Treat, MD
Professor, Department of Hematology/Oncology; Vice Chair, Education; Medical Director, Ambulatory Care, Fox Chase Cancer Center

Radiological Evaluation of the Surgical Patient with CT/PET)

Maruti Kumaran, MD, MBBS, FRCR
Associate Professor, Radiology, Lewis Katz School of Medicine at Temple University

Multidisciplinary Panel Discussion

Joseph Friedberg, MD, FACS
Thoracic Surgeon-in-Chief, Temple University Health System Vice Chair, Surgical Services, Department of Thoracic Medicine and Surgery Co-Director, Temple-Fox Chase Cancer Center Mesothelioma and Pleural Disease Program Professor, Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University

Register

Registration Deadline: Tuesday, October 18, 2022

Inquiries

Lucía Tono, PhD, MEd: 215-728-3797
Lucia.Tono-Ramirez@tuhs.temple.edu

Objectives

• Identify patients who might benefit from neoadjuvant chemo-immunotherapy with early stage lung cancer
• Discuss surgical issues related to this approach
• Explain the role of biomarker testing in this setting

Intended Audience

Medical, surgical and radiation oncologists, thoracic and general surgeons, pulmonologists, gastroenterologists, pathologists, radiologists, fellows/residents/students, nurses, physician assistants, and advanced practice clinicians involved in the management of patients with lung cancer and thoracic malignancies.

Accreditation Statement

The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.

Designation Statement

The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity Collapse

Program Directors

Alexander Kutikov, MD, FACS
Chief, Division of Urology and Urologic Oncology; Professor, Department of Surgical Oncology; Roberta R. Scheller Chair in Urologic Oncology

Daniel M. Geynisman, MD
Chief, Division of Genitourinary Medical Oncology; Associate Professor, Department of Hematology/Oncology

Presenters and Topics

Andres Correa, MD
Novel Transperineal Prostate Cancer Related Procedures

Jessica Karen Wong, MD, MEng
Adjuvant vs. Salvage Radiation Therapy for Prostate Cancer: New Data

Elias Obeid, MD, MPH
The Role of Genetic Evaluations and Counseling for Men with Prostate Cancer

Fern Anari, MD
Data Behind the Approvals of Key Hormonal, Chemotherapeutic, and Targeted Systemic Treatments for Advanced Disease

Mike Yu, MD, FACNM, FRCPC
New Imaging Technology in Prostate Cancer

Intended Audience

The program is designed for medical, surgical, and radiation oncologists; urologists; radiologists; primary care physicians; fellows; residents; and other healthcare providers.

Accreditation Statement

The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.

Designation Statement

The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity.

Inquiries

Lucía Tono, PhD, MEd: 215-728-3797
Lucia.Tono-Ramirez@tuhs.temple.edu

Download Event Flyer

  Collapse

Presenters

Program Director

Lori J. Goldstein, MD, FASCO
Professor Emerita, Department of Hematology/Oncology, Fox Chase Cancer Center

Fox Chase Cancer Center Faculty

Richard J. Bleicher, MD, FACS
Professor, Department of Surgical Oncology; Leader, Breast Cancer Program; Director, Breast Fellowship Program

Lori J. Goldstein, MD, FASCO
Professor Emerita, Department of Hematology/Oncology, Fox Chase Cancer Center

Elias Obeid, MD, MPH
Interim Chief, Division of Breast Medical Oncology; Assistant Professor, Department of Clinical Genetics and Department of Hematology/Oncology; Director, Breast, Ovarian and Prostate Cancer Risk Assessment

Kristen D. Whitaker, MD, MS
Assistant Professor, Department of Clinical Genetics and Department of Hematology/Oncology

Penn Medicine's Abramson Cancer Center Faculty

Susan M. Domchek, MD
Executive Director, Basser Center for BRCA; Director, MacDonald Cancer Risk Evaluation Center; Basser Professor in Oncology

Angela DeMichele, MD, MSCE
Jill & Alan Miller Endowed Chair in Breast Cancer Excellence; Professor of Medicine; Co-Leader, Breast Cancer Program; Co-Director, 2-PREVENT Translational Center of Excellence

Learning Objectives

After attending this program, participants should be able to:

• Analyze the advances in the management of breast cancer and premalignant breast disease and, when clinically relevant, integrate new findings into the management of patients with breast cancer and premalignant breast disease.
• When clinically relevant, apply new strategies for optimizing existing treatments into the management of these patients.
• Analyze new developments in breast cancer research and current available clinical trials and, when clinically relevant, include this information in discussions with patients.

  Collapse